All News OmniAb, Inc.

Equities

OABI

US68218J1034

Real-time Estimate Cboe BZX Other stock markets 08:09:30 16/05/2024 pm IST			5-day change	1st Jan Change
4.575 ^USD	+0.77%		-0.33%	-26.18%

09/05	Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M	MT
09/05	OmniAb, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit	16/05	BU
Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M	10/05	MT
OmniAb, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
Transcript : OmniAb, Inc., Q1 2024 Earnings Call, May 09, 2024	10/05
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights	10/05	BU
OmniAb to Participate in Five Investor Conferences in May	01/05	BU
OmniAb to Report First Quarter 2024 Financial Results on May 9	22/04	BU
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate Biotherapeutics	16/04	AQ
OmniAb : March 2024 Corporate Overview	27/03	PU
OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing	25/03	MT
Sector Update: Health Care Stocks Gain Pre-Bell Thursday	21/03	MT
OmniAb Swings to Q4 Loss, Revenue Declines	21/03	MT
Earnings Flash (OABI) OMNIAB Posts Q4 Revenue $4.8M, vs. Street Est of $7.46M	21/03	MT
Transcript : OmniAb, Inc., Q4 2023 Earnings Call, Mar 20, 2024	21/03
OmniAb, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/03	CI
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	21/03	BU
OmniAb to Report Fourth Quarter 2023 Financial Results on March 20	26/02	BU
OmniAb to Participate in Two Investor Conferences in March	20/02	BU
OmniAb, Inc.(NasdaqGM:OABI) added to NASDAQ Biotechnology Index	18/12	CI
OmniAb Presents New Scientific Data on its OmnidAb Platform at the 2023 Antibody Engineering and Therapeutics Conference	15/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News OmniAb, Inc.

Equities

OABI

US68218J1034

All News

Filters